Interviews & Appearances

Diversity, Equity, and Inclusion (DEI) have catalyzed transformative change across the healthcare sector. Specifically, DEI in clinical research aims to ensure that anyone who may one day take medication or use a device in their healthcare journey has their lived experience with disease or health included in the design and implementation of clinical research. This is to improve the representation of historically underserved communities by clinical research and to increase the potential of new drugs and devices to be as safe and effective as possible.

In the dynamic landscape of healthcare, patient advocacy plays a crucial role in bridging the gap between scientific and clinical understanding and the individuals and communities who will rely on those discoveries. Devra Densmore is the visionary founder and principal consultant at Elevate Advocacy. With an illustrious career spanning two decades, Devra has been instrumental in reshaping patient advocacy and engagement, particularly through a lens of diversity, equity, and inclusion (DEI).

Devra Densmore, principal consultant at Elevate Advocacy, explains the FDA has released guidance to drive Diversity Action Plans to ensure that clinical trials are representative of affected patients. Emphasizing the need for a thoughtful and strategic approach to diversity, Devra highlights inclusivity includes accessibility and listening to patient advocates to meet the needs of marginalized communities.